[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].
Identifieur interne : 000438 ( Ncbi/Merge ); précédent : 000437; suivant : 000439[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].
Auteurs : P. Stingl [Allemagne]Source :
- MMW Fortschritte der Medizin [ 1438-3276 ] ; 2000.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- diagnostic : Éléphantiasis.
- Calendrier d'administration des médicaments, Humains, Éléphantiasis.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- diagnosis : Elephantiasis.
- prevention & control : Elephantiasis.
- Drug Administration Schedule, Humans.
Abstract
Lymphatic filariasis currently affects some 120 million people in 73 tropical countries. Almost one-half of all those affected have manifest signs and symptoms of disease, of which elephantiasis is the most serious. A large majority of the remainder have subclinical lymphopathy and nephropathy. New scientific discoveries give rise to the hope that the global elimination of this disease--which is associated with physical disfigurement, sexual dysfunction and social decline--might be possible. Today, we have available simple diagnostic tools and highly effective, safe and cost-effective medications. New insights into the pathogenesis now make it possible to alleviate individual suffering and prevent further progression of the disease.
PubMed: 10992767
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004994
- to stream PubMed, to step Curation: 004994
- to stream PubMed, to step Checkpoint: 004994
Links to Exploration step
pubmed:10992767Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].</title><author><name sortKey="Stingl, P" sort="Stingl, P" uniqKey="Stingl P" first="P" last="Stingl">P. Stingl</name><affiliation wicri:level="4"><nlm:affiliation>Abteilung für Infektions- und Tropenmedizin, Klinikum der Ludwig-Maximilians-Universität München.</nlm:affiliation><country>Allemagne</country><placeName><settlement type="city">Munich</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region></placeName><orgName type="university">Université Louis-et-Maximilien de Munich</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10992767</idno><idno type="pmid">10992767</idno><idno type="wicri:Area/PubMed/Corpus">004994</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004994</idno><idno type="wicri:Area/PubMed/Curation">004994</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004994</idno><idno type="wicri:Area/PubMed/Checkpoint">004994</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004994</idno><idno type="wicri:Area/Ncbi/Merge">000438</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].</title><author><name sortKey="Stingl, P" sort="Stingl, P" uniqKey="Stingl P" first="P" last="Stingl">P. Stingl</name><affiliation wicri:level="4"><nlm:affiliation>Abteilung für Infektions- und Tropenmedizin, Klinikum der Ludwig-Maximilians-Universität München.</nlm:affiliation><country>Allemagne</country><placeName><settlement type="city">Munich</settlement><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region></placeName><orgName type="university">Université Louis-et-Maximilien de Munich</orgName></affiliation></author></analytic><series><title level="j">MMW Fortschritte der Medizin</title><idno type="ISSN">1438-3276</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term><term>Diethylcarbamazine (administration & dosage)</term><term>Drug Administration Schedule</term><term>Elephantiasis (diagnosis)</term><term>Elephantiasis (prevention & control)</term><term>Filaricides (administration & dosage)</term><term>Humans</term><term>Ivermectin (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (administration et posologie)</term><term>Calendrier d'administration des médicaments</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Filaricides (administration et posologie)</term><term>Humains</term><term>Ivermectine (administration et posologie)</term><term>Éléphantiasis ()</term><term>Éléphantiasis (diagnostic)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Elephantiasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Éléphantiasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Administration Schedule</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Calendrier d'administration des médicaments</term><term>Humains</term><term>Éléphantiasis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis currently affects some 120 million people in 73 tropical countries. Almost one-half of all those affected have manifest signs and symptoms of disease, of which elephantiasis is the most serious. A large majority of the remainder have subclinical lymphopathy and nephropathy. New scientific discoveries give rise to the hope that the global elimination of this disease--which is associated with physical disfigurement, sexual dysfunction and social decline--might be possible. Today, we have available simple diagnostic tools and highly effective, safe and cost-effective medications. New insights into the pathogenesis now make it possible to alleviate individual suffering and prevent further progression of the disease.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10992767</PMID><DateCreated><Year>2000</Year><Month>11</Month><Day>15</Day></DateCreated><DateCompleted><Year>2000</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1438-3276</ISSN><JournalIssue CitedMedium="Print"><Volume>142</Volume><Issue>31-32</Issue><PubDate><Year>2000</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>MMW Fortschritte der Medizin</Title><ISOAbbreviation>MMW Fortschr Med</ISOAbbreviation></Journal><ArticleTitle>[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].</ArticleTitle><Pagination><MedlinePgn>38-9</MedlinePgn></Pagination><Abstract><AbstractText>Lymphatic filariasis currently affects some 120 million people in 73 tropical countries. Almost one-half of all those affected have manifest signs and symptoms of disease, of which elephantiasis is the most serious. A large majority of the remainder have subclinical lymphopathy and nephropathy. New scientific discoveries give rise to the hope that the global elimination of this disease--which is associated with physical disfigurement, sexual dysfunction and social decline--might be possible. Today, we have available simple diagnostic tools and highly effective, safe and cost-effective medications. New insights into the pathogenesis now make it possible to alleviate individual suffering and prevent further progression of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stingl</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Abteilung für Infektions- und Tropenmedizin, Klinikum der Ludwig-Maximilians-Universität München.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Elephantiasis bald ausgerottet? Neue Therapiekonzepte ermöglichen Massenbehandlung.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>MMW Fortschr Med</MedlineTA><NlmUniqueID>100893959</NlmUniqueID><ISSNLinking>1438-3276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical><Chemical><RegistryNumber>F4216019LN</RegistryNumber><NameOfSubstance UI="D015766">Albendazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015766" MajorTopicYN="N">Albendazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004604" MajorTopicYN="N">Elephantiasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>9</Month><Day>19</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>9</Month><Day>19</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10992767</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Bavière</li><li>District de Haute-Bavière</li></region><settlement><li>Munich</li></settlement><orgName><li>Université Louis-et-Maximilien de Munich</li></orgName></list><tree><country name="Allemagne"><region name="Bavière"><name sortKey="Stingl, P" sort="Stingl, P" uniqKey="Stingl P" first="P" last="Stingl">P. Stingl</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000438 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000438 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:10992767
|texte= [Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:10992767" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |